S-Alpha Therapeutics, Inc.
7 clinical trials · Sponsor
◉ Watch S-Alpha Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Extension Study on Safety and Rebound Effect of SAT-001 for Myopia in Children (NCT06742268) | S-Alpha Therapeutics, Inc. | 2024-12-16 |
| Pivotal Trial of SAT-014 for Trauma and Stressor-Related Disorder Symptoms (NCT06734858) | S-Alpha Therapeutics, Inc. | 2024-12-09 |
| Exploratory Study on the Effect of SAT-001 on Choroidal Thickness in Pediatric Myopia Patients (NCT06729723) | S-Alpha Therapeutics, Inc. | 2024-08-19 |
| Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014, a Software for Alleviating Symptoms of Trauma and Stress-related Disorders (NCT06439407) | S-Alpha Therapeutics, Inc. | 2024-01-03 |
| Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia (NCT06344572) | S-Alpha Therapeutics, Inc. | 2023-09-27 |
Track S-Alpha Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.